Diffusion tensor imaging of subcortical brain injury in patients infected with human immunodeficiency virus

Journal of NeuroVirology

Volumn 11, Issue 3, 2005, Pages 292-298

  Ragin, Anne B ^a,c   Wu, Ying ^a,b   Storey, Pippa ^a,b   Cohen, Bruce A ^a   Edelman, Robert R ^a,b   Epstein, Leon G ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b EVANSTON NORTHWESTERN HEALTHCARE   (United States)

^c Department of Radiology ^*  (United States)

Author keywords

Basal ganglia; HIV dementia; Quantitative MR

Indexed keywords

CD4 ANTIGEN;

ADULT; ANEMIA; ANISOTROPY; ARTICLE; BASAL GANGLION; BRAIN FUNCTION; BRAIN INJURY; BRAIN REGION; CAUDATE NUCLEUS; CLINICAL ARTICLE; CLINICAL FEATURE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; CORRELATION ANALYSIS; DIFFUSION; DIFFUSION TENSOR IMAGING; DISEASE PREDISPOSITION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VIVO STUDY; LYMPHOCYTE COUNT; MALE; MEMORY DISORDER; NEUROANATOMY; PATHOLOGICAL ANATOMY; PRIORITY JOURNAL; PUTAMEN; QUANTITATIVE ANALYSIS; SENSITIVITY ANALYSIS; VERBAL MEMORY; VISUAL MEMORY; WORKING MEMORY;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 23744476277     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.1080/13550280590953799     Document Type: Article

References (48)

1. An H, Chen Y, Smith KJ, Hall C, Robertson K, Wilber K, Robertson W, Kwock L, Lin W (2004). Whole brain fractional anisotropy analysis in HIV patients with elastic registration. [Abstract] International Society of Magnetic Resonance in Medicine, 2483, Kyoto, Japan, May 2004.
2. Avison MJ, Nath A, Berger JR (2002). Understanding pathogenesis and treatment of HIV dementia: a role for magnetic resonance. Trends Neurosci 25: 468-473.
3. Aylward EH, Brettschneider PD, McArthur JC, Harris GJ, Schlaepfer TE, Henderer JD, Barta PE, Tien AY, Pearlson GD (1995). Magnetic resonance imaging measurement of gray matter volume reductions in HIV dementia. Am J Psychiatry 152: 987-994.
4. Basser PJ, Pierpaoli C (1996). Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI. J Magn Reson B 111: 209-219.
5. Bell JE (1998). The neuropathology of adult HIV infection. Rev Neurol 154: 816-829.
6. Bencherif B, Rottenberg DA (1998). Neuroimaging of the AIDS dementia complex. AIDS 12: 233-244.
7. Benton AL (1955). The Visual Retention Test. New York: The Psychological Corporation.
8. Carasig D, Chang L, Arnold S, Tomasi D, Cloak C, Ernst T. (2003). A voxel-based morphometric study of HIV-1 patients at 4 tesla. [Abstract] International Society of Magnetic Resonance in Medicine, 2638, Toronto, Canada, July 2003.
9. Cherner M, Masliah E, Ellis RJ, Marcotte TD, Moore DJ, Grant I, Heaton RK (2002). Neurocognitive dysfunction predicts postmortem findings of HIV encephalitis. Neurology 59: 1563-1567.
10. Cloak CC, Chang L, Miller E, Ernst T (2003). Increased subcortical diffusion is associated with poorer cognitive scores in HIV [Abstract]. International Society of Magnetic Resonance in Medicine, 2239.
11. Concha M, Selnes OA, McArthur J, Nance-Sproson T, Updike ML, Royal W 3rd, Solomon L, Vlahov D (1995). Normative data for a brief neuropsychologic test battery in a cohort of injecting drug users. Intl J Addict 30: 832-841.
12. Everall IP, Chong WK, Wilkinson ID, Paley MN, Chinn RJ, Hall-Craggs MA, Scaravilli F, Lantos PL, Luthert PJ, Harrison MJ (1997). Correlation of MRI and neuropathology in AIDS. J Neurol Neurosurg Psychiatry 62: 92-95.
13. Fahn S, Marsden C, Calne D (1987). Developments in Parkinson's disease. Florham Park, New Jersey: Macmillan Healthcare Information.
14. Filippi CG, Uluǧ AM, Ryan E, Ferrando SJ, van Gorp W (2001). Diffusion tensor imaging of patients with HIV and normal-appearing white matter on MR images of the brain. AJNR Am J Neuroradiol 22: 277-283.
15. Filippi M, Grossman RI (2002). MRI techniques to monitor MS evolution: the present and the future. Neurology 58: 1147-1153.
16. Flowers KA, Robertson C (1985). The effects of Parkinson's disease on the ability to maintain a mental set. J Neurol Neurosurg Psychiatr 48: 517-529.
17. Gartner S (2000). HIV infection and dementia. Science 287: 602-604.
18. Gartner S, Liu Y (2002). Insights into the role of immune activation in HIV neuropathogenesis. J NeuroVirol 8: 69-75.
19. Gass A, Niendorf T, Hirsch JG (2001). Acute and chronic changes of the apparent diffusion coefficient in neurological disorders-biophysical mechanisms and possible underlying histopathology. J Neurol Sci 186: S15-S23.
20. Green HA, Pena A, Price CJ, Warburton EA, Pickard JD, Carpenter TA, Gillard JH (2002). Increased anisotropy in acute stroke: a possible explanation. Stroke 33: 1517-1521.
21. He JZ, Greco JB, Mui K, Aminipour S, Kim J, Fuller R, Rataj E, Lentz M, Sehgal P, Westmoreland SV, de Crespigny A, Gonzalex RG (2003). Diffusion MR detection of early white matter changes in the SIV primate model of neuroaids. [Abstract] International Society of Magnetic Resonance in Medicine, 2536.
22. Horsfield MA, Jones DK (2002). Applications of diffusion-weighted and diffusion tensor MRI to white matter diseases - a review. NMR Biomed 15: 570-577.
23. Klove H (1963). Clinical neuropsychology. Med Clin North Am 46: 1647-1658.
24. Le Bihan D (2003). Looking into the functional architecture of the brain with diffusion MRI. Nat Rev Neurosci 4: 469-480.
25. Lipton SA, Gendelman HE (1995). Seminars in medicine of the Beth Israel Hospital, Boston. Dementia associated with the acquired immunodeficiency syndrome. N Engl J Med 332: 934-940.
26. Marder K, The Dana Consortium on therapy for HIV dementia and related cognitive disorders (1996). Clinical confirmation of the American Academy of Neurology algorithm for HIV-1-associated cognitive/motor disorder. Neurology 47: 1247-1253.
27. Marder K, Albert SM, McDermott MP, McArthur JC, Schifitto G, Selnes OA, Sacktor N, Stern Y, Palumbo D, Kieburtz K, Cohen B, Orme C, Epstein LG (2003). Inter-rater reliability of a clinical staging of HIV-associated cognitive impairment. Neurology 60: 1467-1473.
28. McArthur J, Hoover D, Bacellar H, Miller EN, Cohen BA, Becker JT, Graham NM, McArthur JH, Selnes OA, Jacobson LP, Visscher BR, Concha M, Saah A (1993). Dementia in AIDS patients: incidence and risk factors. Multicenter AIDS Cohort Study. Neurology 43: 2245-2252.
29. Middleton FA, Strick PL (2000). Basal ganglia and cerebellar loops: motor and cognitive circuits. Brain Res Rev 31: 236-250.
30. Miller EN, Satz P, Visscher B (1991). Computerized and conventional neuropsychological assessment of HIV-1 infected homosexual men. Neurology 41: 1608-1616.
31. Mottershead JP, Schmierer K, Clemence M, Thornton JS, Scaravilli F, Barker GJ, Tofts PS, Newcombe J, Cuzner ML, Ordidge RJ, McDonald WI, Miller DH (2003). High field MRI correlates of myelin content and axonal density in multiple sclerosis. A post-mortem study of the spinal cord. J Neurol 250: 1293-1301.
32. Moyle G. (2002). Anaemia in persons with HIV infection: prognostic marker and contributor to morbidity. AIDS Rev 4: 13-20.
33. Nebuloni M, Pellegrinelli A, Ferri A, Bonetto S, Boldorini R, Vago L, Grassi MP, Constanzi G (2001). Beta amyloid precursor protein and patterns of HIV p24 immunohistochemistry in different brain areas of AIDS patients. AIDS 15: 571-575.
34. Nelson PT, Soma LA, Lavi E (2002). Microglia in diseases of the central nervous system. Ann Med 34: 491-500.
35. Pomara N, Crandall DT, Choi SJ, Johnson G, Lim KO (2001). White matter abnormalities in HIV-1 infection: a diffusion tensor imaging study. Psychiatry Res 106: 15-24.
36. Ragin AB, Storey P, Cohen BA, Edelman RR, Epstein LG (2004a). Disease burden in HIV-associated cognitive impairment: a study of whole brain imaging measures. Neurology 63: 2293-2297.
37. Ragin AB, Storey P, Cohen BA, Epstein LG, Edelman RR (2004b). Whole brain diffusion tensor imaging in HIV-associated cognitive impairment. AJNR Am J Neuroradiol 25: 195-200.
38. Raja F, Sherriff FE, Morris CS, Bridges LR, Esiri MM (1997). Cerebral white matter damage in HIV infection demonstated using β-amyloid precursor protein immunoreactivity. Acta Neuropathol 93: 184-189.
39. Rey A (1941). L'examen psychologique dans les cas d'encephalopathie traumatique. Arch Psychol 28: 286-340.
40. Ring HA, Serra-Mestres J (2002). Neuropsychiatry of the basal ganglia. J Neurol Neurosurg Psychiatr 72: 12-21.
41. Selnes OA, Jacobson L, Machado AM, Becker JT, Wesch J, Miller EN, Visscher B, McArthur JC (1991). Normative data for a brief neuropsychological screening battery. Percept Mot Skills 73: 539-550.
42. Sevigny JJ, Albert SM, McDermott MP, McArthur JC, Sacktor N, Conant K, Schifitto G, Selnes OA, Stern Y, McClernon DR, Palumbo D, Kieburtz K, Riggs G, Cohen B, Epstein LG, Marder K (2004). Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated Dementia. Neurology 63: 2084-2090.
43. Sidtis JJ, Gatsonis C, Price RW, Singer EJ, Collier AC, Richman DD, Hirsch MS, Schaerf FW, Fischl MA, Kieburtz K, Simpson D, Kach MA, Feinberg J, Dafni U, The Aids Clinical Trials Group (1993). Ziduvodine treatment of the AIDS dementia complex-results of a placebo-controlled trial. Ann Neurol 33: 343-349.
44. Smith JJ, Sorensen AG, Thrall JH (2003). Biomarkers in imaging: realizing Radiology's future. Radiology 227: 633-638.
45. Tyor WR, Wesselingh SL, Griffin JW, McArthur JC, Griffin DE (1995). Unifying hypothesis for the pathogenesis of HIV-associated dementia complex, vacuolar myelopathy, and sensory neuropathy. J Acquir Immune Defic Syndr Hum Retrovirol 9: 379-388.
46. Wechsler D (1981). Wechsler Adult Intelligence Scale - Revised. New York: The Psychological Corporation.
47. Yang Q, Tress BM, Barber PA, Desmond PM, Darby DG, Gerraty RP, Li T, Davis SM (1999). Serial study of apparent diffusion coefficient and anisotropy in patients with acute stroke. Stroke 30: 2382-2390.
48. Zgaljardic DJ, Borod JC, Foldi NS, Mattis P (2003). A review of the cognitive and behavioral sequelae of Parkinson's Disease: relationship to frontostriatal circuitry. Cogn Behav Neurol 16: 193-210.